{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-215234","form_type":"8-K","ticker":"VERA","cik":"0001831828","company_name":"Vera Therapeutics, Inc.","filed_at":"2021-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.954332+00:00","generated_at":"2026-06-30T05:30:02.954206+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vera Therapeutics appoints Sean P. Grant as CFO; Jonathan Wolter resigns","bullets":["Sean P. Grant named CFO effective July 12, 2021; annual base salary $400,000.","Grant receives option to purchase 180,000 shares vesting over 4 years.","Previous CFO Jonathan Wolter resigned effective July 14, 2021; no disagreement cited.","Grant previously VP of Corporate Strategy at CareDx and VP in Citigroup Healthcare Investment Banking.","Employment letter includes severance of 9 months salary (12 months on change in control)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-215234","json":"https://secwatch.observer/filing/0001193125-21-215234.json","markdown":"https://secwatch.observer/filing/0001193125-21-215234.md","text":"https://secwatch.observer/filing/0001193125-21-215234.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831828/000119312521215234/0001193125-21-215234-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831828/000119312521215234/d185242d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T05:30:02.954206+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6217cd86fd","claim":"Sean P. Grant was appointed as Chief Financial Officer at Vera Therapeutics, Inc..","evidence_excerpt":"On July 14, 2021, Vera Therapeutics, Inc. (the “Company”) announced the appointment of Sean P. Grant as the Company’s Chief Financial Officer, effective July 12, 2021 (the “Start Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831828/000119312521215234/0001193125-21-215234-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}